Somnigroup International heads into the back half of August with a stock down 10% on the month and short sellers quietly reducing exposure — a subtle divergence from the persistent bearishness that has defined the name all year.
The short-side story has turned modestly constructive. Short interest fell roughly 4.5% on the week to 6.5% of the free float, continuing a gradual retreat from levels above 7% seen earlier in the summer. The ORTEX short score has also eased — dropping to 56.6 from a week-high of 66.9 on August 20, when a spike in reported short shares proved short-lived. Borrow conditions remain unthreatening: cost to borrow is running at just 0.57%, barely moved on the week, and availability is wide open at 276% of short interest — meaning shares available to lend comfortably exceed current short positions. That kind of borrow looseness rules out any near-term mechanical squeeze pressure.
Options positioning tells a more bullish story than the short interest data alone. The put/call ratio is running at 0.10, well below its 20-day average of 0.13 and roughly 1.6 standard deviations beneath it — the most call-heavy configuration in recent weeks. That sits nowhere near the 52-week high of 0.62, which represents the most defensive the options market has been over the past year. Right now, options activity reflects conviction in the upside case, not hedging against further downside.
The Street broadly agrees with that directional lean, though with diminishing enthusiasm on valuation. After the August 6 earnings print — which sent the stock down 6.2% on the day — analysts from UBS, Piper Sandler, and Truist all maintained positive ratings but trimmed targets into the $94–$100 range, down from prior marks between $102 and $115. Morgan Stanley initiated with an Overweight and a $95 target in late July, adding a fresh bull voice. The consensus mean target of around $89 implies roughly 39% upside from the current $64.09 price, a gap that reflects both genuine analyst conviction and the scale of the year-to-date de-rating. The PE has compressed to roughly 19.6x on trailing earnings, with EV/EBITDA near 13.9x — neither cheap nor demanding by sector standards, but meaningfully below where the stock traded when targets were set in the $100+ range. The analyst recommendation differential factor ranks in the 96th percentile, flagging that the Street skew toward Buy-equivalent ratings is unusually pronounced relative to the broader universe.
Institutional ownership adds texture to the bull case. FMR and BlackRock together hold over 20% of shares, with both adding modestly through July. State Street increased its position by nearly 390,000 shares in the most recent period, while Browning West — an active manager known for engagement — added 473,000 shares as of June 30. The Linonia Partnership trimmed by just over two million shares in the same period, providing the notable counterweight. Insider data is stale past the 90-day threshold and should be treated as background context only.
The most recent earnings release is the clearest near-term reference point. The August 6 print produced a 6.2% single-day decline and the stock shed a further 4.7% over the following five days. The next event is scheduled for November 5. Between now and then, the key tension is whether the combination of easing short interest, call-heavy options flow, and dense analyst buy coverage can gain traction against a stock that has consistently disappointed on the tape — or whether the housing-adjacent demand environment keeps the fundamental narrative too soft for the bull case to close that 39% gap.
See the live data behind this article on ORTEX.
Open SGI on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
